Switzer TV

This week's Switzer Report sees us celebrating the new year. The new financial year, that is. We get our expert stock pickers - Jun Bei Liu of TenCap and Adam Dawes of Shaw and Partners - to give us three stocks each that they're eyeing in the new year. We're also joined by Propertyology's Simon Pressley about what property prices will dowhen we turn over the financial calendar.

Plus, Paul Rickard joins us to talk about Xero's recent $3.9 billon acquisition.

 

 

Subscribe to Switzer

  • Switzer Report - https://switzerreport.com.au/subscribe
  • Switzer Daily - https://switzer.com.au/subscribe
Switzer Investing TV | 30 June 2025: A new (financial) year is here - what would our experts buy on the share market?

We got our stock pickers to show us three stocks each that they're eyeing in the new year. Here are their new financial year stocks. Plus: what's going to happen with house pricing in the near-term?

More videos

A new therapy for Pancreatic Cancer

Dr Ross Walker explains how pancreatic cancer works and how an Australian company is developing a new therapy to improve the survival rate of this cancer.

Series:
Are these ASX hot stocks a buy: AIS, ALC, MP1, AD8 + The CEO of Bendigo Bank, is this a buy too?

Medallion Financial Group's Michael Wayne, Bendigo and Adelaide Bank's Marnie Baker and Neuberger Berman's Vivek Bommi join Peter Switzer.

Series:
Mad about Money Live

Tune in to hear Peter Switzer and Paul Rickard discuss all the big money stories of the day!

Series:
ALU & APX really a buy? Should you buy Woolies ahead of the demerger with Dan Murphy's?

Burman Invest's Julia Lee, Fairmont Equities' Michael Gable and Switzer's Paul Rickard join the show.

Series:
A new treatment for tinnitus

Almost 20% of the population suffer from the annoying condition called Tinnitus, which presents as a ringing noise in the ear. Dr Ross Walker discusses the ‘poor man’s’ treatment and a new promising treatment for the condition.

Series:
Charlie Aitken names his best OS and OZ stocks: MSFT, MC, GOOGL, CSL & more

Aitken Investment Management's Charlie Aitken, nabtrade's Gemma Dale and Switzer's Paul Rickard join the show.

Series:
Mad about Money Live

Find out the latest money news and how it affects you with Peter Switzer and Paul Rickard.

Series:
ASX Stocks the experts like: Z1P, ALU, CSL, GNC & is EML a buy after the sell-off?

Burman Invest's Julia Lee, Shaw and Partners' Adam Dawes and Switzer's Paul Rickard join Peter Switzer on this week's show.

Series:
Coming soon: exciting new technology that could change medicine as we know it

Dr Ross Walker explains microneedle patch technology and how it will revolutionise treatments for diabetics, people with high cholesterol and anyone needing injections or vaccinations.

Series:
Are these ASX stocks a buy: NXL, AVH, TWE, MP1, ALL, XRO + how to borrow to buy stocks?

Michael Gable from Fairmont Equities, Paul Rickard from Switzer, Lily Elliott from Bendigo and Adelaide Bank, and Ying Yi Ann Cheng from Coolabah Capital join Peter Switzer.

Series:
Mad about Money

Join Peter Switzer and Paul Rickard for the latest episode of our weekly show Mad about Money.

Series:
Altium (ALU), Appen (APX), A2Milk (A2M), are the AAA stocks worth buying?

In this episode: Burman Invest's Julia Lee, Tribeca's Jun Bei Liu and Switzer's Paul Rickard.

Series:
1 30 31 32 33 34 50

Fill in the form below to subscribe to Switzer Daily and get our latest articles, videos and podcasts sent straight to your inbox

Get the latest financial, business, and political expert commentary delivered to your inbox.

When you sign up, we will never give away or sell or barter or trade your email address.

And you can unsubscribe at any time!
Subscribe
© 2006-2021 Switzer. All Rights Reserved. Australian Financial Services Licence Number 286531. 
shopping-cartphoneenvelopedollargraduation-cap linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram